Interest Expense of NRX Pharmaceuticals, Inc. from 30 Jun 2020 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: NRX Pharmaceuticals, Inc. quarterly and annual Interest Expense in USD history and change rate from 30 Jun 2020 to 31 Mar 2024.
NRX Pharmaceuticals, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $230,000.
NRX Pharmaceuticals, Inc. annual Interest Expense for 2023 was $120,000.
NRX Pharmaceuticals, Inc. annual Interest Expense for 2021 was $18,000, a 68% decline from 2020.
Source SEC data: View on sec.gov

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Change (%)

NRX Pharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024		$230,000			01 Jan 2024	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q3 2023		$40,000			01 Jul 2023	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q1 2022	$16,000	$3,000	-$2,000	-40%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q4 2021	$18,000	$3,000			01 Oct 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021		$5,000	-$7,513	-60%	01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2022	Q3
Q2 2021		$5,000	+$2,468	+97%	01 Apr 2021	30 Jun 2021	10-Q	15 Aug 2022	2022	Q2
Q1 2021		$5,000			01 Jan 2021	31 Mar 2021	10-Q	16 May 2022	2022	Q1
Q3 2020		$12,513			01 Jul 2020	30 Sep 2020	10-Q/A	12 Aug 2022	2021	Q3
Q2 2020		$2,532			01 Apr 2020	30 Jun 2020	10-Q/A	12 Aug 2022	2021	Q2

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$120,000			01 Jan 2023	31 Dec 2023	10-K	29 Mar 2024	2023	FY
2021	$18,000	-$38,000	-68%	01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2020	$56,000			01 Jan 2020	31 Dec 2020	10-K	31 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.